Breaking News Instant updates and real-time market news.

EDIT

Editas Medicine

$13.81

0.55 (4.15%)

04:55
10/19/16
10/19
04:55
10/19/16
04:55

Editas Medicine management to meet with JPMorgan

Meetings to be held in Los Angeles on October 18 and in San Francisco/San Mateo on October 19 hosted by JPMorgan.

  • 19

    Oct

EDIT Editas Medicine
$13.81

0.55 (4.15%)

02/29/16
02/29/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. JPMorgan analyst Brian Ossenbeck initiated a cautious outlook for the North American truckload sector, saying he believes "tepid" freight demand and a lack of a boost to consumer spending from low gas prices will lead the first contraction in realized revenue per loaded mile since 2007. Ossenteck initiated Werner (WERN) with an Overweight rating due to expectations that its diversification will drive a re-rating of its shares. The analyst set a Neutral rating on Swift Transport (SWFT) and Ryder (R), and an Underweight rating on Heartland Express (HTLD) and Knight Transportation (KNX). 2. Editas Medicine (EDIT) initiated with an Outperform at Cowen and JMP Securities, and a Neutral at JPMorgan. Cowen cited the company's "world-class expertise" in CRISPR, which will enable the development of a broad pipeline. JPMorgan analyst Cory Kasimov added that the company's CRISPR gene editing platform has the potential to be a game changer, but that it has "limited value-inflecting news" likely to come in 2016. 3. BeiGene (BGNE) initiated with an Outperform at Cowen citing the proof-of-concept data on each of four clinical candidates and expects to monetize those assets on the global stage. The company was also initiated with an Overweight and a Buy at Morgan Stanley and Goldman, respectively. 4. Nielsen (NLSN) initiated with a Buy at Jefferies by analyst Ryan Cary, who said the company is well positioned to benefit from demand for cross-platform viewership measurement and greenfield in emerging markets provides protection against macro headwinds. 5. Square (SQ) initiated with a Sector Weight at Pacific Crest by analyst Josh Beck, who said his optimism is balanced by the market's high expectations for execution, the uncertain regulatory environment for SMB lending, and software initiatives. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, Reference Link
06/02/16
JEFF
06/02/16
INITIATION
Target $35
JEFF
Hold
Editas Medicine initiated with a Hold at Jefferies
Jefferies analyst Gena Wang started Editas Medicine with a Hold rating and $35 price target.
06/21/16
JANY
06/21/16
NO CHANGE
Target $48
JANY
Buy
Janney says Editas may be weak after UPenn scientists first to Cas9 RAC
Janney Capital analyst Roy Buchanan noted that members of the NIH's Recombinant DNA Advisory Committee, or RAC, were supportive of a phase 1 trial proposed by scientists at the University of Pennsylvania to test the use of CRISPR-Cas9 to create genetically altered immune cells to attack cancer. Buchanan noted shares of Editas Medicine may be impacted since the company will not be the first to the Cas9 RAC, as had been expected, but he noted this academic study will address a limited patient population, adding that "there is plenty of CAR-T/TCR space left to operate". The firm has a Buy rating and $48 fair value estimate on Editas shares.
08/10/16
JEFF
08/10/16
UPGRADE
Target $35
JEFF
Buy
Editas Medicine upgraded to Buy from Hold at Jefferies
Jefferies analyst Gena Wang upgraded Editas Medicine to Buy saying the recent pullback in the shares provides an opportunity to own the company's "transformative CRIPSR technology." The analyst keeps a $35 price target for the shares.

TODAY'S FREE FLY STORIES

KNX

Knight Transportation

$36.45

0.45 (1.25%)

11:31
12/05/16
12/05
11:31
12/05/16
11:31
Conference/Events
Knight Transportation management to meet with Stephens »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBR

Nabors Industries

$17.50

0.445 (2.61%)

11:30
12/05/16
12/05
11:30
12/05/16
11:30
Options
Calendar spreads in Nabors trading with hefty markup »

Calendar spreads in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:30
12/05/16
12/05
11:30
12/05/16
11:30
General news
Treasury Futures Action: a large block purchase of Ultra bonds »

Treasury Futures Action:…

ABMD

Abiomed

$108.87

1.48 (1.38%)

11:26
12/05/16
12/05
11:26
12/05/16
11:26
Conference/Events
Abiomed management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

DISCA

Discovery

$26.60

-0.55 (-2.03%)

11:25
12/05/16
12/05
11:25
12/05/16
11:25
Hot Stocks
Breaking Hot Stocks news story on Discovery »

Discovery up nearly 3% as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SUM

Summit Materials

$23.46

0.2 (0.86%)

11:20
12/05/16
12/05
11:20
12/05/16
11:20
Conference/Events
Summit Materials management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

P

Pandora

$13.59

0.255 (1.91%)

11:20
12/05/16
12/05
11:20
12/05/16
11:20
Options
Bullish option play opened in Pandora »

Bullish option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DISCA

Discovery

$26.60

-0.55 (-2.03%)

, T

AT&T

$38.75

0.14 (0.36%)

11:18
12/05/16
12/05
11:18
12/05/16
11:18
Hot Stocks
Discovery CEO says 'well positioned' to take product direct to consumer in 2017 »

Discovery (DISCA) says…

DISCA

Discovery

$26.60

-0.55 (-2.03%)

T

AT&T

$38.75

0.14 (0.36%)

TWX

Time Warner

$93.84

0.04 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

  • 07

    Dec

SCG

SCANA

$70.63

-0.29 (-0.41%)

11:18
12/05/16
12/05
11:18
12/05/16
11:18
Hot Stocks
SCANA, Westinghouse receive order from DRB about construction milestone payment »

South Carolina Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$30.86

0.06 (0.19%)

11:18
12/05/16
12/05
11:18
12/05/16
11:18
Hot Stocks
BeiGene: BGB-3111 'highly active' in CLL/SLL, well tolerated in Phase 1 study »

BeiGene presented updated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

NKE

Nike

$51.77

1.31 (2.60%)

11:16
12/05/16
12/05
11:16
12/05/16
11:16
Technical Analysis
Nike moves to monthly highs, levels to watch »

The stock is up over 3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

TGTX

TG Therapeutics

$5.50

0.05 (0.92%)

11:16
12/05/16
12/05
11:16
12/05/16
11:16
Hot Stocks
TG Therapeutics announces oral data presentation for TGR-1202 at ASH »

TG Therapeutics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

$NYE

NYSE Market Internals

11:16
12/05/16
12/05
11:16
12/05/16
11:16
Technical Analysis
NYSE market internals summary »

Breadth is bullish across…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

11:16
12/05/16
12/05
11:16
12/05/16
11:16
Technical Analysis
NASDAQ market internals summary »

Volume is very light for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NYT

New York Times

$13.00

0.2 (1.56%)

11:15
12/05/16
12/05
11:15
12/05/16
11:15
Periodicals
New York Times sees more-than-tenfold increase in daily subs, Politico reports »

The New York Times has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

11:15
12/05/16
12/05
11:15
12/05/16
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:15
12/05/16
12/05
11:15
12/05/16
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

GWPH

GW Pharmaceuticals

$112.32

3.04 (2.78%)

11:14
12/05/16
12/05
11:14
12/05/16
11:14
Recommendations
GW Pharmaceuticals analyst commentary  »

GW Pharmaceuticals price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

ORA

Ormat Technologies

$47.50

0.17 (0.36%)

11:14
12/05/16
12/05
11:14
12/05/16
11:14
Conference/Events
Ormat Technologies management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

FGP

Ferrellgas Partners LP

$6.20

0.55 (9.73%)

11:13
12/05/16
12/05
11:13
12/05/16
11:13
Upgrade
Ferrellgas Partners LP rating change  »

Ferrellgas Partners LP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

ULTA

Ulta Beauty

$253.39

-4.02 (-1.56%)

11:12
12/05/16
12/05
11:12
12/05/16
11:12
Conference/Events
Ulta Beauty management to meet with Oppenheimer »

Field trip to company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 13

    Dec

RSX

Market Vectors Russia ETF

$20.25

0.41 (2.07%)

11:10
12/05/16
12/05
11:10
12/05/16
11:10
Options
Bullish option action in the VanEck Vectors Russia Fund »

Bullish option action in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:10
12/05/16
12/05
11:10
12/05/16
11:10
General news
Treasury announced a $45 B 4-week bill sale for Tuesday »

Treasury announced a $45…

CDK

CDK Global

$56.91

-0.24 (-0.42%)

11:07
12/05/16
12/05
11:07
12/05/16
11:07
Conference/Events
CDK Global management to meet with Oppenheimer »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

11:05
12/05/16
12/05
11:05
12/05/16
11:05
General news
More from Evans: analysts're on cusp of period of rising rates »

More from Evans:…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.